Your browser doesn't support javascript.
loading
Potentiality of multiple modalities for single-cell analyses to evaluate the tumor microenvironment in clinical specimens.
Kashima, Yukie; Togashi, Yosuke; Fukuoka, Shota; Kamada, Takahiro; Irie, Takuma; Suzuki, Ayako; Nakamura, Yoshiaki; Shitara, Kohei; Minamide, Tatsunori; Yoshida, Taku; Taoka, Naofumi; Kawase, Tatsuya; Wada, Teiji; Inaki, Koichiro; Chihara, Masataka; Ebisuno, Yukihiko; Tsukamoto, Sakiyo; Fujii, Ryo; Ohashi, Akihiro; Suzuki, Yutaka; Tsuchihara, Katsuya; Nishikawa, Hiroyoshi; Doi, Toshihiko.
Afiliação
  • Kashima Y; Division of Translational Genomics, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Chiba, 277-8577, Japan.
  • Togashi Y; Division of Cancer Immunology, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Chiba, Japan.
  • Fukuoka S; Division of Cancer Immunology, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Chiba, Japan.
  • Kamada T; Division of Cancer Immunology, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Chiba, Japan.
  • Irie T; Division of Cancer Immunology, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Chiba, Japan.
  • Suzuki A; Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Chiba, Japan.
  • Nakamura Y; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, 277-8577, Japan.
  • Shitara K; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, 277-8577, Japan.
  • Minamide T; Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East, Chiba, Japan.
  • Yoshida T; Drug Discovery Research, Astellas Pharma, Inc., Ibaraki, Japan.
  • Taoka N; Drug Discovery Research, Astellas Pharma, Inc., Ibaraki, Japan.
  • Kawase T; Drug Discovery Research, Astellas Pharma, Inc., Ibaraki, Japan.
  • Wada T; Oncology Research Laboratories I, DaiichiSankyo. Co., Ltd., Tokyo, Japan.
  • Inaki K; Biomarker & Translational Research Department, DaiichiSankyo. Co., Ltd., Tokyo, Japan.
  • Chihara M; Oncology Research Laboratories I, DaiichiSankyo. Co., Ltd., Tokyo, Japan.
  • Ebisuno Y; Takeda Pharmaceutical Company Ltd., Fujisawa, Japan.
  • Tsukamoto S; Axcelead Drug Discovery Partners Inc., Fujisawa, Japan.
  • Fujii R; Axcelead Drug Discovery Partners Inc., Fujisawa, Japan.
  • Ohashi A; Division of Translational Genomics, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Chiba, 277-8577, Japan. aohashi@east.ncc.go.jp.
  • Suzuki Y; Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Chiba, Japan.
  • Tsuchihara K; Division of Translational Informatics, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Chiba, Japan.
  • Nishikawa H; Division of Cancer Immunology, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Chiba, Japan.
  • Doi T; Experimental Therapeutics, National Cancer Center Hospital East, Chiba, Japan. tdoi@east.ncc.go.jp.
Sci Rep ; 11(1): 341, 2021 01 11.
Article em En | MEDLINE | ID: mdl-33431933

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Análise de Célula Única / Microambiente Tumoral Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Sci Rep Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Análise de Célula Única / Microambiente Tumoral Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Sci Rep Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão